Update on review of COVID-19 Vaccine AstraZeneca and thromboembolic events with concurrent low platelet counts

In view of the available data, the CHM says COVID-19 Vaccine AstraZeneca is contraindicated in patients with a history of major venous and arterial thrombosis with thrombocytopenia. But the overall the vaccine benefits against COVID-19 continue to outweigh any risks in the vast majority of people.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in